victoza glp 1 👍 The FDA has approved the first generic liraglutide injection (18 mg/3 ml), providing a new option for managing type 2 diabetes (T2D) in patients 10 years and older. This GLP-1 receptor A new study suggests GLP-1s

Limited Scope of FDA Approval The most significant limitation is the narrow approved indication: FDA approval restricted exclusively to acquired, generalized hypoactive sexual desire disorder in premenopausal women No approved indication for men despite Phase 2 evidence of erectile dysfunction improvement No approval for postmenopausal women No approval for other forms of sexual dysfunction beyond HSDD All use outside this single indication represents off-label prescribing based on limited clinical trial data and physician clinical experience

The specific patterns include: counterfeit products (contents not matching the label), compounded semaglutide from non-pharmacy sources (no batch quality control), telemedicine-only prescribing without adequate medical assessment, and absence of the contraindication screening and monitoring that proper clinical use requires

It's a poor fit if you have substantial weight to lose, because that's precisely what the full-dose programs are built and proven for, or if you're not willing to do the check-ins that stand in for the evidence nobody has published yet

Schlgl H, Kabisch S, Horstmann A, Lohmann G, Mller K, Lepsien J, et al

Adipose tissue-derived adiponectin, 179 a type of lipokine that includes palmitoleic acid (C16:1n7), 180 contributes to interorgan communication with tissues such as the liver and muscle, with a potential role in ameliorating insulin resistance and type 2 diabetes in humans